Literature DB >> 1448088

Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding.

E Shaulian1, A Zauberman, D Ginsberg, M Oren.   

Abstract

Mutations in the p53 gene are most frequent in cancer. Many p53 mutants possess transforming activity in vitro. In cells transformed by such mutants, the mutant protein is oligomerized with endogenous cell p53. To determine the relevance of oligomerization for transformation, miniproteins containing C-terminal portions of p53 were generated. These miniproteins, although carrying no point mutation, transformed at least as efficiently as full-length mutant p53. Transforming activity was coupled with the ability to oligomerize with wild-type p53, as well as with the ability to abrogate sequence-specific DNA binding by coexpressed wild-type p53. These findings suggest that p53-mediated transformation may operate through a dominant negative mechanism, involving the generation of DNA binding-incompetent oligomers.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1448088      PMCID: PMC360497          DOI: 10.1128/mcb.12.12.5581-5592.1992

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  76 in total

1.  Nuclear accumulation of p53 protein is mediated by several nuclear localization signals and plays a role in tumorigenesis.

Authors:  G Shaulsky; N Goldfinger; A Ben-Ze'ev; V Rotter
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

2.  Subcellular distribution of the p53 protein during the cell cycle of Balb/c 3T3 cells.

Authors:  G Shaulsky; A Ben-Ze'ev; V Rotter
Journal:  Oncogene       Date:  1990-11       Impact factor: 9.867

3.  Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen expression.

Authors:  W E Mercer; M T Shields; D Lin; E Appella; S J Ullrich
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

4.  Nuclear localization is essential for the activity of p53 protein.

Authors:  G Shaulsky; N Goldfinger; M S Tosky; A J Levine; V Rotter
Journal:  Oncogene       Date:  1991-11       Impact factor: 9.867

5.  A DNA binding domain is contained in the C-terminus of wild type p53 protein.

Authors:  O S Foord; P Bhattacharya; Z Reich; V Rotter
Journal:  Nucleic Acids Res       Date:  1991-10-11       Impact factor: 16.971

6.  Modulation of immortalizing properties of human papillomavirus type 16 E7 by p53 expression.

Authors:  T Crook; C Fisher; K H Vousden
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

Review 7.  p53 mutations in human cancers.

Authors:  M Hollstein; D Sidransky; B Vogelstein; C C Harris
Journal:  Science       Date:  1991-07-05       Impact factor: 47.728

8.  A potential transcriptional activation element in the p53 protein.

Authors:  R W O'Rourke; C W Miller; G J Kato; K J Simon; D L Chen; C V Dang; H P Koeffler
Journal:  Oncogene       Date:  1990-12       Impact factor: 9.867

9.  Analysis of p53 mutants for transcriptional activity.

Authors:  L Raycroft; J R Schmidt; K Yoas; M M Hao; G Lozano
Journal:  Mol Cell Biol       Date:  1991-12       Impact factor: 4.272

10.  Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6.

Authors:  E Yonish-Rouach; D Resnitzky; J Lotem; L Sachs; A Kimchi; M Oren
Journal:  Nature       Date:  1991-07-25       Impact factor: 49.962

View more
  125 in total

1.  c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release.

Authors:  P Juin; A O Hueber; T Littlewood; G Evan
Journal:  Genes Dev       Date:  1999-06-01       Impact factor: 11.361

Review 2.  Soft tissue sarcomas and p53 mutations.

Authors:  H Taubert; A Meye; P Würl
Journal:  Mol Med       Date:  1998-06       Impact factor: 6.354

3.  Change of the death pathway in senescent human fibroblasts in response to DNA damage is caused by an inability to stabilize p53.

Authors:  A Seluanov; V Gorbunova; A Falcovitz; A Sigal; M Milyavsky; I Zurer; G Shohat; N Goldfinger; V Rotter
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

4.  Mutually compensatory mutations during evolution of the tetramerization domain of tumor suppressor p53 lead to impaired hetero-oligomerization.

Authors:  M G Mateu; A R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

5.  Integrity of the N-terminal transcription domain of p53 is required for mutant p53 interference with drug-induced apoptosis.

Authors:  D Matas; A Sigal; P Stambolsky; M Milyavsky; L Weisz; D Schwartz; N Goldfinger; V Rotter
Journal:  EMBO J       Date:  2001-08-01       Impact factor: 11.598

6.  Tetraploid state induces p53-dependent arrest of nontransformed mammalian cells in G1.

Authors:  P R Andreassen; O D Lohez; F B Lacroix; R L Margolis
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

7.  v-Src generates a p53-independent apoptotic signal.

Authors:  B L Webb; E Jimenez; G S Martin
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

8.  Nucleolar disruption and apoptosis are distinct neuronal responses to etoposide-induced DNA damage.

Authors:  Maciej Pietrzak; Scott C Smith; Justin T Geralds; Theo Hagg; Cynthia Gomes; Michal Hetman
Journal:  J Neurochem       Date:  2011-05-13       Impact factor: 5.372

9.  RNA polymerase 1-driven transcription as a mediator of BDNF-induced neurite outgrowth.

Authors:  Cynthia Gomes; Scott C Smith; Mark N Youssef; Jing-Juan Zheng; Theo Hagg; Michal Hetman
Journal:  J Biol Chem       Date:  2010-11-23       Impact factor: 5.157

10.  Planck-Benzinger thermal work function: thermodynamic characterization of the carboxy-terminus of p53 peptide fragments.

Authors:  Paul W Chun; Marc S Lewis
Journal:  Protein J       Date:  2010-11       Impact factor: 2.371

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.